Pandox revenue and financials

PNDX.B · Nasdaq Stockholm · SEK

kr 151.20Change from previous close: +0.80%Absolute change: +kr 1.20

Close · October 6, 2026

In the fiscal year ended December 2025, Pandox reported revenue of kr 7.47B (+4.67% year over year). Net income was kr 3.14B, a net margin of 42.0%.

Annual revenue · 2025: kr 7.47B
  1. kr 5.65B2022
  2. kr 6.85B2023
  3. kr 7.14B2024
  4. kr 7.47B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+4.67%
2025 vs 2024
Net income growth
+85.85%
2025 vs 2024
Net margin
42.0%
2024: 23.7%

Financial data

Amounts in millions of SEK; per-share values in SEK; shares in millions.

Income statement · Annual
Item20252024202320222021
Total revenue7,4697,1366,8495,654—
Cost of revenue3,2473,2813,2622,550—
Gross profit4,2223,8553,5873,104—
Selling, general and administrative236200197153—
Operating income3,9863,6553,3902,951—
EBIT5,9214,6861,5856,339—
EBITDA6,2524,9731,8716,673—
Interest expense2,0752,3272,082988—
Pre-tax income3,8462,359-4975,351—
Income tax67265383.01,147—
Net income3,1391,689-5854,217—
Net income to common shareholders3,1391,689-5854,217—
Basic EPS16.139.04-3.1822.94—
Diluted EPS16.139.04-3.1822.94—
Average shares (basic)195187184184—
Average shares (diluted)195187184184—